We interviewed 14 R&D biopharma leaders on the critical success factors for building a Best Practice R&D organization. This report shares what we learned.

See how Guardant Health is increasing access to in-country liquid biopsy testing through partnerships with world-renowned labs and academic centers around the globe. Download Now.

Single cell RNA sequencing uncovers tissue heterogeneity by providing gene expression measurements in individual cells within the tissue. This level of resolution allows for a clearer understanding of specific cellular functions, tissue complexity, and is a powerful tool to discover therapeutic targets and novel biomarkers. Download now to learn more.

The use of prefilled syringes to administer biotherapeutics is beginning to gain traction because they offer a range of stability, efficacy, and patient safety benefits. Download this white paper to learn how Lonza has developed a novel workflow to ensure confidence regarding functionality in PFS and autoinjectors.

The Fierce 50 is a constellation of the most brilliant visionaries and trailblazers, handpicked by the discerning editors of Fierce Life Sciences and Healthcare. These are the movers and shakers who are pushing boundaries, defying limitations and igniting change in healthcare delivery, drug development, research and beyond.